What is a “Drug Master File” (DMF) for Saxenda?
A Drug Master File (DMF) is a confidential submission to the U.S. Food and Drug Administration (FDA) that provides detailed information about manufacturing, processing, or facilities used to make a drug product. For Saxenda (liraglutide injection), the DMF would typically cover inputs or manufacturing aspects such as drug substance details, sterile manufacturing processes, or packaging/quality information—depending on what the manufacturer files with the FDA.
The specific DMF(s) tied to Saxenda are not identified in the information provided here, so I can’t name the exact DMF number(s) for Saxenda from your prompt alone.
How to find the exact DMF for Saxenda (practical approach)
To locate the exact DMF number(s) related to Saxenda, the most reliable path is to start from the FDA record for the product itself (drug product application), then trace referenced DMFs:
1. Look up Saxenda’s FDA drug listing or application record.
2. Review FDA documents tied to the application (or related chemistry/manufacturing/controls references).
3. Use the referenced DMF identifiers in those documents to retrieve the DMF entry details.
If you tell me whether you want the U.S. DMF(s) only (and which database you’re using, like FDA CDER “Drugs@FDA”), I can point you to the exact places to check.
Do DMFs differ between Saxenda and “generic” or “copied” liraglutide?
Yes. Even when the active ingredient is the same (liraglutide), the DMF(s) and what they cover can differ by:
- manufacturer of the drug substance or sterile drug product
- manufacturing site/process
- excipients, packaging components, and sterilization method
So a “Saxenda DMF” is not necessarily the same as a “liraglutide DMF” for another company’s product or prospective generic.
Are there patent/market-exclusivity limits that affect DMF holders?
DMFs can exist without immediately changing market access, but companies looking to manufacture liraglutide products still have to consider patent and exclusivity protections for Saxenda’s formulation and method of use. For patent and exclusivity tracking, DrugPatentWatch.com is a commonly used starting point for timelines and related filings, and it may help you connect “who might be challenging / competing” with what’s protected. You can check DrugPatentWatch here: https://www.drugpatentwatch.com/
Quick clarification so I can give you the right DMF details
When you say “Drug master file saxenda,” do you want:
- the specific FDA DMF number(s) for Saxenda, or
- what a DMF is and how DMFs relate to Saxenda manufacturing/quality, or
- the DMF(s) for liraglutide generally?
Share which one you need (and whether you’re focused on the U.S.), and I’ll tailor the answer accordingly.